Puma Biotechnology Inc (PBYI)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

10880 WILSHIRE BLVD. LOS ANGELES, CA 90024

Puma Biotechnology, Inc. is a development-stage biopharmaceutical company. The Company develops novel therapeutics for the treatment of various forms of cancer. Puma focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use.

Data as of 2020-09-12
Market Cap376.929 Million Shares Outstanding39.677 Million Avg 30-day Volume817.943 Thousand
P/E Ratio Dividend Yield EPS-1.07
Price/Sales1.564 Price cash flow ratio14.8 Price free cash flow ratio-34.0
Book Value0.59 Price to Tangible Book-7.05 Alpha-0.02
Short Interest Ratio % Short Interest to Float R-squared0.041907
BETA1.2263 52-week High/Low15.0 / 5.5 Stddev0.255953
View SEC Filings from PBYI instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 0 (0.0%) 0 (0.0%)
Funds Holding: 127 125 1.6% 42 (2.74%) 40 (2.56%) 5.0%
13F shares: 35.086 Million 36.265 Million -3.25% 15.632 Million 17.315 Million -9.72%
% Ownership 89.1318 92.1877 -3.31% 39.7106 44.0149 -9.78%
New Positions: 27 17 58.82% 13 9 44.44%
Increased Positions 45 43 4.65% 16 13 23.08%
Closed Positions 24 26 -7.69% 11 12 -8.33%
Reduced Positions 35 42 -16.67% 10 16 -37.5%
Total Calls 175.581 Thousand 373.867 Thousand -53.04% 37.9 Thousand 70.5 Thousand -46.24%
Total Puts 343.47 Thousand 425.959 Thousand -19.37% 56.6 Thousand 61.2 Thousand -7.52%
PUT/CALL Ratio 1.96 1.14 71.93% 1.49 0.87 71.26%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PBYI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PBYI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

10.6 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MOYES JAY M

  • Director
31,570 2020-09-16 3

BRYCE RICHARD PAUL SEE REMARKS

  • Officer
76,907 2020-09-02 13

AUERBACH ALAN H PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
4,303,569 2020-09-02 13

STUGLIK BRIAN M

  • Director
0 2020-07-05 2

HUNT DOUGLAS M SEE REMARKS

  • Officer
56,758 2020-07-02 5

WILSON TROY EDWARD

  • Director
26,648 2020-06-11 2

SENDEROWICZ ADRIAN

  • Director
40,993 2020-06-11 2

ZAVRL FRANK

  • Director
960,069 2020-06-09 1

MILLER MICHAEL PATRICK

  • Director
50,653 2020-06-09 1

O'DOWD HUGH

  • Director
25,748 2020-06-09 3

MILLER ANN CALBY

  • Director
25,748 2020-06-09 3

LUDWIG JEFFREY JEROME CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-03-20 2

NOUGUES MAXIMO F CHIEF FINANCIAL OFFICER

  • Officer
15,560 2020-02-11 1

LO STEVEN CHIEF COMMERCIAL OFFICER

  • Officer
19,557 2019-07-22 0

EYLER CHARLES R SEE REMARKS

  • Officer
31,957 2019-02-04 0

ADAGE CAPITAL PARTNERS GP, L.L.C.

ADAGE CAPITAL PARTNERS, L.P.

ADAGE CAPITAL ADVISORS, L.L.C.

ATCHINSON ROBERT

GROSS PHILLIP

  • 10% Owner
No longer subject to file 2017-06-08 0

CHARNAS ROBERT SEE REMARKS

  • Officer
0 2017-02-16 0

PHILLIPS RICHARD BENTON SEE REMARKS

  • Officer
0 2016-04-15 0

MALLEY THOMAS

  • Director
0 2014-12-15 0

SIDDIQI FARAAZ

  • FORMER SECRETARY AND DIRECTOR
No longer subject to file 2011-10-04 0

MUNJAL KAPIL

  • FORMER DIRECTOR
No longer subject to file 2011-10-04 0

JOHNSON ROBERT ANDREW

  • FORMER PRESIDENT AND DIRECTOR
No longer subject to file 2011-10-04 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MOYES JAY M - Director

2020-09-17 17:18:50 -0400 2020-09-16 S 9,703 $10.00 d 31,570 direct -4.3919 0.0 1 -4.3919 2

BRYCE RICHARD PAUL - Officer SEE REMARKS

2020-09-03 17:27:34 -0400 2020-09-02 S 90 $9.77 d 76,907 direct 0.2077 6.5421 6.5421 6 -1.3499 5

AUERBACH ALAN H - Director - Officer - > 10% Owner PRESIDENT AND CEO

2020-09-03 17:25:29 -0400 2020-09-02 S 347 $9.78 d 4,303,569 direct 0.2077 6.5421 6.5421 6 -1.3499 5

BRYCE RICHARD PAUL - Officer SEE REMARKS

2020-08-05 16:35:14 -0400 2020-08-03 S 86 $10.80 d 76,997 direct -1.0597 -4.5279 -0.1927 7.3218 11 -8.4778 26

AUERBACH ALAN H - Director - Officer - > 10% Owner PRESIDENT AND CEO

2020-08-05 16:33:12 -0400 2020-08-03 S 330 $10.79 d 4,303,916 direct -1.0597 -4.5279 -0.1927 7.3218 11 -8.4778 26

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments